Intelligent Follow-up of Neonatal Jaundice Based on Early Indicators and Internet Communications
Hyperbilirubinemia, Neonatal
About this trial
This is an interventional prevention trial for Hyperbilirubinemia, Neonatal focused on measuring End tidal carbon monoxide, Internet Plus, jaundice follow-up management model
Eligibility Criteria
Inclusion Criteria:
- gestational age between 35(+0)~41(+6)
- birth weight ≥ 2500 g
- ethics approval obtained
- parental consent obtained
Exclusion Criteria:
- severe perinatal asphyxia
- infectious diseases
- persistent need for respiratory support
- major congenital malformation
- inborn errors of metabolism
- pathological neonatal hyperbilirubinemia due to the defects of red blood cell membrane and erythrocyte enzyme
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
innavative modeled strategy
traditional strategy
In this arm, the risk evaluation before discharge for hyperbilirubenemia needing further intervention is based on Bhutani nomogram and end tidal carbon monoxide corrected for ambient carbon monoxide. Assessment result includes high risk, median risk, low risk and delayed discharge. Internet Plus technology is applied in follow-up management.
In this arm, the risk evaluation before discharge for hyperbilirubenemia needing further intervention is based on Bhutani nomogram and the follow-up table advised by the Chinese guideline for neonatal hyperbilirubinemia. Assessment result includes high risk, median risk and low risk. Traditional outpatient is applied in follow-up management.